English
简体中文
Total: £ 56.28
Published Date: 2026-01-22 | Pages: 140 | Tables: 124 | Medical Care
The global First-in-Human (FIH) Services market was valued at US$ 751 million in 2025 and is anticipated to reach US$ 1576 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development.
The North American market for First-in-Human (FIH) Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for First-in-Human (FIH) Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for First-in-Human (FIH) Services in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of First-in-Human (FIH) Services include WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global First-in-Human (FIH) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding First-in-Human (FIH) Services. The First-in-Human (FIH) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global First-in-Human (FIH) Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist First-in-Human (FIH) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
WuXi AppTec
Allucent
Altasciences
LAXAI
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec
Aixial Group
Quotient Sciences
Sofpromed
Spaulding Clinical
Biotrial
Crystal Pharmatech Co., Ltd
Avania
Segment by Type
Drugs
Medical Device
Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic Institutions and Research Centers
Medical Device Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for First-in-Human (FIH) Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global First-in-Human (FIH) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drugs
1.2.3 Medical Device
1.3 Market by Application
1.3.1 Global First-in-Human (FIH) Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic Institutions and Research Centers
1.3.5 Medical Device Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global First-in-Human (FIH) Services Market Perspective (2021–2032)
2.2 Global First-in-Human (FIH) Services Growth Trends by Region
2.2.1 Global First-in-Human (FIH) Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 First-in-Human (FIH) Services Historic Market Size by Region (2021–2026)
2.2.3 First-in-Human (FIH) Services Forecasted Market Size by Region (2027–2032)
2.3 First-in-Human (FIH) Services Market Dynamics
2.3.1 First-in-Human (FIH) Services Industry Trends
2.3.2 First-in-Human (FIH) Services Market Drivers
2.3.3 First-in-Human (FIH) Services Market Challenges
2.3.4 First-in-Human (FIH) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top First-in-Human (FIH) Services Players by Revenue
3.1.1 Global Top First-in-Human (FIH) Services Players by Revenue (2021–2026)
3.1.2 Global First-in-Human (FIH) Services Revenue Market Share by Players (2021–2026)
3.2 Global Top First-in-Human (FIH) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by First-in-Human (FIH) Services Revenue
3.4 Global First-in-Human (FIH) Services Market Concentration Ratio
3.4.1 Global First-in-Human (FIH) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by First-in-Human (FIH) Services Revenue in 2025
3.5 Global Key Players of First-in-Human (FIH) Services Head Offices and Areas Served
3.6 Global Key Players of First-in-Human (FIH) Services, Products and Applications
3.7 Global Key Players of First-in-Human (FIH) Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 First-in-Human (FIH) Services Breakdown Data by Type
4.1 Global First-in-Human (FIH) Services Historic Market Size by Type (2021–2026)
4.2 Global First-in-Human (FIH) Services Forecasted Market Size by Type (2027–2032)
5 First-in-Human (FIH) Services Breakdown Data by Application
5.1 Global First-in-Human (FIH) Services Historic Market Size by Application (2021–2026)
5.2 Global First-in-Human (FIH) Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America First-in-Human (FIH) Services Market Size (2021–2032)
6.2 North America First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America First-in-Human (FIH) Services Market Size by Country (2021–2026)
6.4 North America First-in-Human (FIH) Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe First-in-Human (FIH) Services Market Size (2021–2032)
7.2 Europe First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe First-in-Human (FIH) Services Market Size by Country (2021–2026)
7.4 Europe First-in-Human (FIH) Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific First-in-Human (FIH) Services Market Size (2021–2032)
8.2 Asia-Pacific First-in-Human (FIH) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2021–2026)
8.4 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America First-in-Human (FIH) Services Market Size (2021–2032)
9.2 Latin America First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America First-in-Human (FIH) Services Market Size by Country (2021–2026)
9.4 Latin America First-in-Human (FIH) Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa First-in-Human (FIH) Services Market Size (2021–2032)
10.2 Middle East & Africa First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2021–2026)
10.4 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Details
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec First-in-Human (FIH) Services Introduction
11.1.4 WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.1.5 WuXi AppTec Recent Development
11.2 Allucent
11.2.1 Allucent Company Details
11.2.2 Allucent Business Overview
11.2.3 Allucent First-in-Human (FIH) Services Introduction
11.2.4 Allucent Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.2.5 Allucent Recent Development
11.3 Altasciences
11.3.1 Altasciences Company Details
11.3.2 Altasciences Business Overview
11.3.3 Altasciences First-in-Human (FIH) Services Introduction
11.3.4 Altasciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.3.5 Altasciences Recent Development
11.4 LAXAI
11.4.1 LAXAI Company Details
11.4.2 LAXAI Business Overview
11.4.3 LAXAI First-in-Human (FIH) Services Introduction
11.4.4 LAXAI Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.4.5 LAXAI Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza First-in-Human (FIH) Services Introduction
11.5.4 Lonza Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.5.5 Lonza Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health First-in-Human (FIH) Services Introduction
11.6.4 Syneos Health Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.6.5 Syneos Health Recent Development
11.7 CD BioSciences
11.7.1 CD BioSciences Company Details
11.7.2 CD BioSciences Business Overview
11.7.3 CD BioSciences First-in-Human (FIH) Services Introduction
11.7.4 CD BioSciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.7.5 CD BioSciences Recent Development
11.8 Fortrea
11.8.1 Fortrea Company Details
11.8.2 Fortrea Business Overview
11.8.3 Fortrea First-in-Human (FIH) Services Introduction
11.8.4 Fortrea Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.8.5 Fortrea Recent Development
11.9 Certara
11.9.1 Certara Company Details
11.9.2 Certara Business Overview
11.9.3 Certara First-in-Human (FIH) Services Introduction
11.9.4 Certara Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.9.5 Certara Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec First-in-Human (FIH) Services Introduction
11.10.4 Evotec Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.10.5 Evotec Recent Development
11.11 Aixial Group
11.11.1 Aixial Group Company Details
11.11.2 Aixial Group Business Overview
11.11.3 Aixial Group First-in-Human (FIH) Services Introduction
11.11.4 Aixial Group Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.11.5 Aixial Group Recent Development
11.12 Quotient Sciences
11.12.1 Quotient Sciences Company Details
11.12.2 Quotient Sciences Business Overview
11.12.3 Quotient Sciences First-in-Human (FIH) Services Introduction
11.12.4 Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.12.5 Quotient Sciences Recent Development
11.13 Sofpromed
11.13.1 Sofpromed Company Details
11.13.2 Sofpromed Business Overview
11.13.3 Sofpromed First-in-Human (FIH) Services Introduction
11.13.4 Sofpromed Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.13.5 Sofpromed Recent Development
11.14 Spaulding Clinical
11.14.1 Spaulding Clinical Company Details
11.14.2 Spaulding Clinical Business Overview
11.14.3 Spaulding Clinical First-in-Human (FIH) Services Introduction
11.14.4 Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.14.5 Spaulding Clinical Recent Development
11.15 Biotrial
11.15.1 Biotrial Company Details
11.15.2 Biotrial Business Overview
11.15.3 Biotrial First-in-Human (FIH) Services Introduction
11.15.4 Biotrial Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.15.5 Biotrial Recent Development
11.16 Crystal Pharmatech Co., Ltd
11.16.1 Crystal Pharmatech Co., Ltd Company Details
11.16.2 Crystal Pharmatech Co., Ltd Business Overview
11.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Introduction
11.16.4 Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.16.5 Crystal Pharmatech Co., Ltd Recent Development
11.17 Avania
11.17.1 Avania Company Details
11.17.2 Avania Business Overview
11.17.3 Avania First-in-Human (FIH) Services Introduction
11.17.4 Avania Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.17.5 Avania Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global First-in-Human (FIH) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Drugs
Table 3. Key Players of Medical Device
Table 4. Global First-in-Human (FIH) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global First-in-Human (FIH) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global First-in-Human (FIH) Services Market Size by Region (US$ Million), 2021–2026
Table 7. Global First-in-Human (FIH) Services Market Share by Region (2021–2026)
Table 8. Global First-in-Human (FIH) Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global First-in-Human (FIH) Services Market Share by Region (2027–2032)
Table 10. First-in-Human (FIH) Services Market Trends
Table 11. First-in-Human (FIH) Services Market Drivers
Table 12. First-in-Human (FIH) Services Market Challenges
Table 13. First-in-Human (FIH) Services Market Restraints
Table 14. Global First-in-Human (FIH) Services Revenue by Players (US$ Million), 2021–2026
Table 15. Global First-in-Human (FIH) Services Market Share by Players (2021–2026)
Table 16. Global Top First-in-Human (FIH) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on First-in-Human (FIH) Services Revenue, 2025
Table 17. Ranking of Global Top First-in-Human (FIH) Services Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by First-in-Human (FIH) Services Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of First-in-Human (FIH) Services, Headquarters and Area Served
Table 20. Global Key Players of First-in-Human (FIH) Services, Products and Applications
Table 21. Global Key Players of First-in-Human (FIH) Services, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global First-in-Human (FIH) Services Market Size by Type (US$ Million), 2021–2026
Table 24. Global First-in-Human (FIH) Services Revenue Market Share by Type (2021–2026)
Table 25. Global First-in-Human (FIH) Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global First-in-Human (FIH) Services Revenue Market Share by Type (2027–2032)
Table 27. Global First-in-Human (FIH) Services Market Size by Application (US$ Million), 2021–2026
Table 28. Global First-in-Human (FIH) Services Revenue Market Share by Application (2021–2026)
Table 29. Global First-in-Human (FIH) Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global First-in-Human (FIH) Services Revenue Market Share by Application (2027–2032)
Table 31. North America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
Table 33. North America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
Table 34. Europe First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
Table 36. Europe First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific First-in-Human (FIH) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
Table 46. WuXi AppTec Company Details
Table 47. WuXi AppTec Business Overview
Table 48. WuXi AppTec First-in-Human (FIH) Services Product
Table 49. WuXi AppTec Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 50. WuXi AppTec Recent Development
Table 51. Allucent Company Details
Table 52. Allucent Business Overview
Table 53. Allucent First-in-Human (FIH) Services Product
Table 54. Allucent Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 55. Allucent Recent Development
Table 56. Altasciences Company Details
Table 57. Altasciences Business Overview
Table 58. Altasciences First-in-Human (FIH) Services Product
Table 59. Altasciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 60. Altasciences Recent Development
Table 61. LAXAI Company Details
Table 62. LAXAI Business Overview
Table 63. LAXAI First-in-Human (FIH) Services Product
Table 64. LAXAI Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 65. LAXAI Recent Development
Table 66. Lonza Company Details
Table 67. Lonza Business Overview
Table 68. Lonza First-in-Human (FIH) Services Product
Table 69. Lonza Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 70. Lonza Recent Development
Table 71. Syneos Health Company Details
Table 72. Syneos Health Business Overview
Table 73. Syneos Health First-in-Human (FIH) Services Product
Table 74. Syneos Health Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 75. Syneos Health Recent Development
Table 76. CD BioSciences Company Details
Table 77. CD BioSciences Business Overview
Table 78. CD BioSciences First-in-Human (FIH) Services Product
Table 79. CD BioSciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 80. CD BioSciences Recent Development
Table 81. Fortrea Company Details
Table 82. Fortrea Business Overview
Table 83. Fortrea First-in-Human (FIH) Services Product
Table 84. Fortrea Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 85. Fortrea Recent Development
Table 86. Certara Company Details
Table 87. Certara Business Overview
Table 88. Certara First-in-Human (FIH) Services Product
Table 89. Certara Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 90. Certara Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec First-in-Human (FIH) Services Product
Table 94. Evotec Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 95. Evotec Recent Development
Table 96. Aixial Group Company Details
Table 97. Aixial Group Business Overview
Table 98. Aixial Group First-in-Human (FIH) Services Product
Table 99. Aixial Group Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 100. Aixial Group Recent Development
Table 101. Quotient Sciences Company Details
Table 102. Quotient Sciences Business Overview
Table 103. Quotient Sciences First-in-Human (FIH) Services Product
Table 104. Quotient Sciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 105. Quotient Sciences Recent Development
Table 106. Sofpromed Company Details
Table 107. Sofpromed Business Overview
Table 108. Sofpromed First-in-Human (FIH) Services Product
Table 109. Sofpromed Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 110. Sofpromed Recent Development
Table 111. Spaulding Clinical Company Details
Table 112. Spaulding Clinical Business Overview
Table 113. Spaulding Clinical First-in-Human (FIH) Services Product
Table 114. Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 115. Spaulding Clinical Recent Development
Table 116. Biotrial Company Details
Table 117. Biotrial Business Overview
Table 118. Biotrial First-in-Human (FIH) Services Product
Table 119. Biotrial Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 120. Biotrial Recent Development
Table 121. Crystal Pharmatech Co., Ltd Company Details
Table 122. Crystal Pharmatech Co., Ltd Business Overview
Table 123. Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product
Table 124. Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 125. Crystal Pharmatech Co., Ltd Recent Development
Table 126. Avania Company Details
Table 127. Avania Business Overview
Table 128. Avania First-in-Human (FIH) Services Product
Table 129. Avania Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
Table 130. Avania Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. First-in-Human (FIH) Services Picture
Figure 2. Global First-in-Human (FIH) Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global First-in-Human (FIH) Services Market Share by Type: 2025 vs 2032
Figure 4. Drugs Features
Figure 5. Medical Device Features
Figure 6. Global First-in-Human (FIH) Services Market Size by Application (US$ Million), 2021–2032
Figure 7. Global First-in-Human (FIH) Services Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Academic Institutions and Research Centers Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. First-in-Human (FIH) Services Report Years Considered
Figure 13. Global First-in-Human (FIH) Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global First-in-Human (FIH) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global First-in-Human (FIH) Services Market Share by Region: 2025 vs 2032
Figure 16. Global First-in-Human (FIH) Services Market Share by Players in 2025
Figure 17. Global First-in-Human (FIH) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by First-in-Human (FIH) Services Revenue in 2025
Figure 19. North America First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America First-in-Human (FIH) Services Market Share by Country (2021–2032)
Figure 21. United States First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe First-in-Human (FIH) Services Market Share by Country (2021–2032)
Figure 25. Germany First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific First-in-Human (FIH) Services Market Share by Region (2021–2032)
Figure 33. China First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America First-in-Human (FIH) Services Market Share by Country (2021–2032)
Figure 41. Mexico First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa First-in-Human (FIH) Services Market Share by Country (2021–2032)
Figure 45. Israel First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. WuXi AppTec Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 49. Allucent Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 50. Altasciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 51. LAXAI Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 52. Lonza Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 53. Syneos Health Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 54. CD BioSciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 55. Fortrea Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 56. Certara Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 57. Evotec Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 58. Aixial Group Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 59. Quotient Sciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 60. Sofpromed Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 61. Spaulding Clinical Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 62. Biotrial Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 63. Crystal Pharmatech Co., Ltd Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 64. Avania Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
